Alessandro Pancrazzi

Alessandro Pancrazzi

UNVERIFIED PROFILE

Are you Alessandro Pancrazzi?   Register this Author

Register author
Alessandro Pancrazzi

Alessandro Pancrazzi

Publications by authors named "Alessandro Pancrazzi"

Are you Alessandro Pancrazzi?   Register this Author

33Publications

787Reads

50Profile Views

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea.

Blood Cancer J 2018 11 22;8(12):122. Epub 2018 Nov 22.

CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi, Firenze, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0152-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250726PMC
November 2018

Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib.

Hematol Oncol 2018 Feb 5;36(1):357-359. Epub 2017 May 5.

CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical medicine, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2424DOI Listing
February 2018

Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology.

Leuk Res 2017 07 23;58:63-72. Epub 2017 Apr 23.

Center for the Study of Myelofibrosis, Biotechnology Research Area, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.04.006DOI Listing
July 2017

Targeted deep sequencing in polycythemia vera and essential thrombocythemia.

Blood Adv 2016 Nov 22;1(1):21-30. Epub 2016 Nov 22.

Centro Ricerca e Innovazione Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; and.

View Article

Download full-text PDF

Source
http://www.bloodadvances.org/lookup/doi/10.1182/bloodadvance
Publisher Site
http://dx.doi.org/10.1182/bloodadvances.2016000216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744051PMC
November 2016

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.

Am J Hematol 2016 09 4;91(9):918-22. Epub 2016 Jul 4.

Department of Experimental and Clinical Medicine and DENOTHE Excellence Center, CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24442DOI Listing
September 2016

JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.

Blood 2015 May;125(21):3352-3

Laboratorio Congiunto Malattie Mieloproliferative Croniche, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy Hematology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-01-62
Publisher Site
http://dx.doi.org/10.1182/blood-2015-01-624536DOI Listing
May 2015

Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.

Pathol Res Pract 2015 Apr 23;211(4):341-3. Epub 2014 Oct 23.

Dipartimento di Medicina Sperimentale e Clinica, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2014.10.004DOI Listing
April 2015

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.

Blood 2014 Mar 26;123(10):1552-5. Epub 2013 Dec 26.

Department of Experimental and Clinical Medicine, University of Florence; and Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-11-538983DOI Listing
March 2014

Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Cancer Epidemiol Biomarkers Prev 2009 Jul 16;18(7):2068-73. Epub 2009 Jun 16.

Unità Funzionale di Ematologia, Dipartimento di Area Critica, Università degli Studi di Firenze, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0353DOI Listing
July 2009

Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds.

Blood 2005 Dec 18;106(13):4102-13. Epub 2005 Aug 18.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-03-1060DOI Listing
December 2005